Home > Press release: AI-Driven Materials Research in Saxony: ...

Even a disease as deadly as idiopathic pulmonary fibrosis (IPF) can start out as just a cough. But as the condition progresses, a person might experience up to 500 respiratory spasms per day.

Some say we’ve entered a new age of AI-enabled scientific discovery. But human insight and creativity still can’t be ...

Researchers create polymer capacitor surviving 482°F temperatures while delivering four times the energy density of current ...

The resin combines flame retardancy and heat resistance for cooling pipes, wiring components, and other applications.

Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United Medical Ltda., has submitted a marketing ...

CAMBRIDGE, Mass., February 12, 2026 - Insilico Medicine (3696.HK), a clinical-stage, generative AI-driven drug discovery company, today announced the launch of a new interactive webpage highlighting ...

Belgian biotech Agomab Therapeutics and eye-focused drug delivery company SpyGlass Pharma both headed to the Nasdaq this ...

The family-friendly EV is Toyota’s fourth electric offering and will be available with two battery options.

Nigeria purchases 1.37 million Chinese electricity meters with a $500m World Bank loan to close a significant metering gap ...

This article explains deposit insurance limits, broker safeguards, and legal recovery mechanisms. It highlights diversification and regulatory awareness as key investor survival ...

Every person with idiopathic pulmonary fibrosis experiences it differently, making each patient's journey unique, says columnist Sam Kirton.